Evidence hub

Autism Spectrum Disorder: cell-therapy evidence by therapy class

Across every stem-cell intervention, ClinicalTrials.gov holds 25 registered records for Autism Spectrum Disorder — 6 recruiting, 1 at Phase 3 or 4, in 14 countries. Snapshot 2026-08-29.

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The condition, and why cells are proposed

Autism is a neurodevelopmental difference, not a lesion to repair, and that framing gap sits under every commercial offer. Registered studies typically test whether immune modulation changes specific behavioural measures. Development itself produces change over months, which is why uncontrolled reports of improvement in children are the least informative data in this entire field.

Therapy classes side by side

Therapy classRegisteredRecruitingPhase 3/4Countries
MSC10406
HSCT3102
exosomes5404
PRP1101

Counts come from separate registry queries per class; a study testing two interventions can appear in more than one row, so rows do not sum to the all-interventions total.

Geography of the research

United States accounts for about 38% of country mentions among sampled studies; 14 countries host at least one site.

CountryStudies with a site there
United States8
Vietnam2
India2
China2
Mexico2
Denmark1
Taiwan1
United Arab Emirates1

The largest registered studies

Sorted by planned enrolment — size is not quality, but a 300-participant trial can answer questions a 12-participant series cannot.

StudyPhaseStatusPlanned nLead sponsorStart
NCT02168868 — Proteomic Biomarker Tests in Blood Samples from Children with Autism Spectrum Disorder (ASD)n/aRecruiting900Benjamin Gesundheit2013-05
NCT07311213 — GENES AND AUTISM - Induced Pluripotent Stem Cellsn/aNot Yet Recruiting450Institut National de la Santé Et de la Recherche Médicale, F2026-08-01
NCT04089579 — hCT-MSC in Children With Autism Spectrum DisorderPhase 2Completed137Joanne Kurtzberg, MD2020-10-12
NCT07622316 — GAIP ASD Research StudyPhase 1Recruiting100Greater Atlanta Integrative Pediatrics2026-06-01
NCT03724136 — Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Studyn/aUnknown100MD Stem Cells2018-10-24
NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research StudyPhase 1, Phase 2Recruiting100Adia Med of Winter Park LLC2026-05-01

Most recently registered

StudyPhaseStatusPlanned nLead sponsorStart
NCT07311213 — GENES AND AUTISM - Induced Pluripotent Stem Cellsn/aNot Yet Recruitingn/aInstitut National de la Santé Et de la Recherche Médicale, F2026-08-01
NCT07622316 — GAIP ASD Research Studyn/aRecruitingn/aGreater Atlanta Integrative Pediatrics2026-06-01
NCT07521384 — Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapyn/aEnrolling By Invitationn/aHealing Hope International2026-06-01
NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Studyn/aRecruitingn/aAdia Med of Winter Park LLC2026-05-01
NCT07546942 — Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Inten/aEnrolling By Invitationn/aBlack Tie Medical, Inc.2026-04-30

Reading this honestly

Treat this as a map of research activity. It tells you whether a claim has an evidence programme behind it — not whether the treatment helped anyone. For Autism Spectrum Disorder specifically, the practical question is which registered study — if any — matches the product a provider is offering, and what its outcome measures actually are.

Frequently asked

How many stem-cell trials exist for Autism Spectrum Disorder?

25 registered records mention a stem-cell intervention for this condition (2026-08-29 snapshot), of which 6 were recruiting.

Which therapy class is furthest along for Autism Spectrum Disorder?

Ranked by Phase 3/4 records: MSC (0), HSCT (0), exosomes (0), PRP (0).

Does a recruiting trial mean I can be treated?

No. Trials have eligibility criteria, and joining one is not the same as buying a treatment. Paying a clinic for an unproven intervention outside a registered study gives you neither the protections nor the data collection of a trial.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads

Download the query data

Download CSV · Download JSON

Query totals are full API matches; status, phase and country counts describe the first up to 400 returned records per query. Query classes overlap and must not be summed as unique trials. Counts are not treatment outcomes. Snapshot: 2026-08-29. Methods and field definitions.